Hostname: page-component-586b7cd67f-dlnhk Total loading time: 0 Render date: 2024-11-26T08:09:07.478Z Has data issue: false hasContentIssue false
  • English
  • Français

Adrenomyeloneuropathy: Report of a New Mutation in a French Canadian Female

Published online by Cambridge University Press:  02 December 2014

Annie Dionne ,
Denis Brunet ,
Alexander McCampbell  and
Nicolas Dupré
Annie Dionne
Affiliation:
Département des Sciences Neurologiques, CHAUQ - Hôpital Enfant-Jésus, Montreal, QC, Canada
Denis Brunet
Affiliation:
Département des Sciences Neurologiques, CHAUQ - Hôpital Enfant-Jésus, Montreal, QC, Canada
Alexander McCampbell
Affiliation:
Department of Neurology, Massachusetts General Hospital, Charlestown, MA, USA
Nicolas Dupré
Affiliation:
Département des Sciences Neurologiques, CHAUQ - Hôpital Enfant-Jésus, and Department of Neurology and Neurosurgery, McGill University, Centre for Research in Neurosciences, Montreal General Hospital, Montreal, QC, Canada
Rights & Permissions [Opens in a new window]

Abstract:

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Background:

X-linked adrenoleukodystrophy is a peroxisomial disorder caused by mutations in the ABCD1 gene. Adrenomyeloneuropathy is the second most frequent phenotype (25-46%) of this disease and classically presents in adulthood with spastic paraparesis. Female heterozygotes can be symptomatic, but they are frequently misdiagnosed as having multiple sclerosis.

Case report:

We report a novel missense mutation in the ABCD1 gene in a 47-year-old French-Canadian female with spastic paraparesis and no confirmed family history of X-linked adrenoleukodystrophy. The mutation is located on exon 1 and causes the amino acid substitution of a valine for an alanine in a region of the protein highly conserved between mouse and man.

Conclusion:

Adrenomyeloneuropathy must be considered in the differential diagnosis of spastic paraparesis in men or women. This is an initial report of an ABCD1 gene mutation in the French-Canadian population, which should lead to the recognition of other cases in the future.

Résumé:

RÉSUMÉ:Introduction:

L’adrénoleucodystrophie liée à l’X est une maladie peroxisomiale causée par une mutation du gène ABCD1. L’adrénomyéloneuropathie en est le deuxième phénotype le plus fréquent (25-46%) et sa manifestation classique à l’âge adulte est une paraparésie spastique. Même les femmes hétérozygotes peuvent être symptomatiques et chez elles un diagnostic erroné de sclérose en plaques est posé fréquemment.

Observation:

Nous rapportons une nouvelle mutation faux-sens du gène ABCD1 chez une Canadienne française de 47 ans atteinte de paraparésie spastique, sans histoire familiale confirmée d’adrénoleucodystrophie. La mutation, située dans l’exon 1, est une substitution d’un seul acide aminé, soit d’une valine par une alanine, dans une région de la protein hautement conservée entre l’homme et la souris.

Conclusion:

L’adrénomyéloneuropathie doit être considérée dans le diagnostic différentiel de la paraparésie spastique chez l’homme et chez la femme. Il s’agit de la première fois qu’une mutation dans le gène ABCD1 est rapportée dans la population canadienne-française, ce qui devrait aider à l’identification d’autres cas à l’avenir.

Type
Case Reports
Information
Canadian Journal of Neurological Sciences , Volume 32 , Issue 2 , May 2005 , pp. 261 - 263
Copyright
Copyright © The Canadian Journal of Neurological 2005

References

1. van Geel, BM, Assies, J, Wanders, RJ, Barth, PG. X-linkedadrenoleukodystrophy: clinical presentation, diagnosis, and therapy. J Neurol Neurosurg Psychiatry 1997;63:4–14.Google Scholar
2. Schmidt, S, Traber, F, Block, W, et al. Phenotype assignment insymptomatic female carriers of X-linked adrenoleukodystrophy. J Neurol 2001;248:36–44.CrossRefGoogle Scholar
3. van Geel, BM, Assies, J, Haverkort, EB, et al. Delay in diagnosis of X-linked adrenoleukodystrophy. Clin Neurol Neurosurg 1993;95: 115–120.Google Scholar
4. Sarde, CO, Mosser, J, Kioschis, P, et al. Genomic organization of the adrenoleukodystrophy gene. Genomics 1994;22:13–20.Google Scholar
5. Valle, D, Gartner, J. Human genetics. Penetrating the peroxisome. Nature 1993;361:682–683.Google Scholar
6. Moser, H, Dubey, P, Fatemi, A. Progress in X-linked adrenoleuko-dystrophy. Curr Opin Neurol 2004;17:263–269.Google Scholar
7. Moser, HW. Adrenoleukodystrophy: phenotype, genetics, patho-genesis and therapy. Brain 1997;120 (Pt 8):1485–1508.Google Scholar
8. Ligtenberg, MJ, Kemp, S, Sarde, CO, et al. Spectrum of mutations in the gene encoding the adrenoleukodystrophy protein. Am J Hum Genet 1995;56:44–50.Google ScholarPubMed
9. Feigenbaum, V, Lombard-Platet, G, Guidoux, S, et al. Mutational andprotein analysis of patients and heterozygous women with X-linked adrenoleukodystrophy. Am J Hum Genet 1996;58:1135–1144.Google Scholar
10. O’Neill, GN, Aoki, M, Brown, RH Jr. ABCD1 translation-initiatormutation demonstrates genotype-phenotype correlation for AMN. Neurology 2001;57:1956–1962.CrossRefGoogle ScholarPubMed
11. Schlote, W, Molzer, B, Peiffer, J, et al. Adrenoleukodystrophy in anadult female. A clinical, morphological, and neurochemical study. J Neurol 1987;235:1–9.CrossRefGoogle Scholar
12. el-Deiry, SS, Naidu, S, Blevins, LS, Ladenson, PW. Assessment of adrenal function in women heterozygous for adrenoleuko-dystrophy. J Clin Endocrinol Metab 1997;82:856–860.Google Scholar